Ironwood Pharmaceuticals reported $97.23M in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acadia Pharmaceuticals ACAD:US $ 134.56M 19.1M
Agios Pharmaceuticals AGIO:US $ 5.58M 4.75M
Akebia Therapeutics AKBA:US $ 126.76M 65.06M
Alnylam Pharmaceuticals ALNY:US $ 224.82M 11.56M
Amarin AMRN:US $ 94.44M 0.19M
Ardelyx ARDX:US $ 2.53M 2.06M
Astellas Pharma 4503:JP Y 381791M 77921M
AstraZeneca AZN:LN 10771M 619M
Astrazeneca AZN:US $ 10771M 619M
Bluebird Bio BLUE:US $ 1.52M 0.43M
Charles River Laboratories CRL:US $ 973.13M 59.2M
Coherus Biosciences CHRS:US $ 60.15M 0.04M
Emergent Biosolutions EBS:US $ 242.7M 64.8M
Esperion Therapeutics ESPR:US $ 18.84M 5K
Exact Sciences EXAS:US $ 521.64M 35.07M
Halozyme Therapeutics HALO:US $ 152.36M 35.09M
Intercept Pharmaceuticals ICPT:US $ 71.76M 16.82M
Ironwood Pharmaceuticals IRWD:US $ 97.23M 0.3M
Karyopharm Therapeutics KPTI:US $ 39.68M 7.99M
Lexicon Pharmaceuticals LXRX:US $ 0.04M 0M
Macrogenics MGNX:US $ 26.01M 14.91M
Moderna Inc MRNA:US 4.75B 1.32B
Myriad Genetics MYGN:US $ 179.3M 14.4M
Pacira Pharmaceuticals PCRX:US $ 169.41M 11.42M
Ptc Therapeutics PTCT:US $ 165.53M 16.79M
Puma Biotechnology PBYI:US $ 59.52M 13.78M
Sarepta Therapeutics SRPT:US $ 233.49M 22.66M
Takeda 4502:JP Y 972465M 99176M
Ultragenyx Pharmaceutical RARE:US $ 89.34M 9.41M
Vanda Pharmaceuticals VNDA:US $ 128.78M 68.59M
YTE INCY:US $ 911.4M 178.16M